Document is current
Any future updates will be listed below
-
Authors
Alexandre, Marie https://orcid.org/0000-0002-3557-7075
Prague, Mélanie https://orcid.org/0000-0001-9809-7848
McLean, Chelsea
Bockstal, Viki
Douoguih, Macaya https://orcid.org/0000-0002-2707-5729
Thiébaut, Rodolphe https://orcid.org/0000-0002-5235-3962
,
Van Effelterre, Thierry
Solforosi, Laura
Bockstal, Viki
Dari, Anna
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative (115854)
Innovative Medicines Initiative (115861)
Innovative Medicines Initiative (800176)
Innovative Medicines Initiative (115854)
Innovative Medicines Initiative (115861)
Innovative Medicines Initiative (800176)
Innovative Medicines Initiative (115854)
Innovative Medicines Initiative (115861)
Innovative Medicines Initiative (800176)
Innovative Medicines Initiative (115854)
Innovative Medicines Initiative (115861)
Innovative Medicines Initiative (800176)
Innovative Medicines Initiative (115854)
Innovative Medicines Initiative (115861)
Innovative Medicines Initiative (800176)
Innovative Medicines Initiative (115854)
Innovative Medicines Initiative (115861)
Innovative Medicines Initiative (800176)
- License Information
-
More Information
Article History
Received: 23 March 2023
Accepted: 13 October 2023
First Online: 8 November 2023
Competing interests
: C.M. and M.D. declare no competing interests but are full-time employees of Janssen Vaccines and Prevention, B.V., and may hold shares of Johnson & Johnson. V.B. declares no competing interests but was a full-time employee of Janssen Vaccines and Prevention at the time of the study and may hold shares of Johnson & Johnson. The other authors declare no competing interests.
